Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured Patients
Early Trauma Induced Coagulopathy (ETIC): A Pilot Study to Determine Its Definition and Risk Factors
Status: Enrolling
Updated:  8/28/2008
Grady Memorial Hospital
mi
from
Atlanta, GA
An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured Patients
Early Trauma Induced Coagulopathy (ETIC): A Pilot Study to Determine Its Definition and Risk Factors
Status: Enrolling
Updated: 8/28/2008
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
The Safety and Efficacy of Intravenous Anti-D for the Treatment of Thrombocytopenia in Patients With HCV Infection Prior to or During Treatment With Pegylated-Interferon and Ribavirin
Status: Enrolling
Updated:  9/25/2008
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
The Safety and Efficacy of Intravenous Anti-D for the Treatment of Thrombocytopenia in Patients With HCV Infection Prior to or During Treatment With Pegylated-Interferon and Ribavirin
Status: Enrolling
Updated: 9/25/2008
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot Study of HSCT for Patients With High-Risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism
Status: Enrolling
Updated:  10/16/2008
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
A Pilot Study of HSCT for Patients With High-Risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism
Status: Enrolling
Updated: 10/16/2008
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
Status: Enrolling
Updated:  12/8/2008
Mount Sinai School of Medicine
mi
from
New York, NY
Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
Status: Enrolling
Updated: 12/8/2008
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
Status: Enrolling
Updated:  12/8/2008
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
Status: Enrolling
Updated: 12/8/2008
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Status: Enrolling
Updated:  1/12/2009
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Status: Enrolling
Updated: 1/12/2009
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Status: Enrolling
Updated:  1/12/2009
University of Pittsburgh Cancer Institute / Hillman Cancer Center
mi
from
Pittsburgh, PA
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Status: Enrolling
Updated: 1/12/2009
University of Pittsburgh Cancer Institute / Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Status: Enrolling
Updated:  1/12/2009
Cancer Therapy and Research Center at the UT Health Sciences Center at San Antonio
mi
from
San Antonio, TX
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Status: Enrolling
Updated: 1/12/2009
Cancer Therapy and Research Center at the UT Health Sciences Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Development and Validation of a Symptom Scale for Children With Chronic Graft-Versus-Host Disease
Development and Validation of a Symptoms Scale for Children With Chronic Graft-Versus-Host Disease
Status: Enrolling
Updated:  1/27/2009
Children's Memorial Hospital
mi
from
Chicago, IL
Development and Validation of a Symptom Scale for Children With Chronic Graft-Versus-Host Disease
Development and Validation of a Symptoms Scale for Children With Chronic Graft-Versus-Host Disease
Status: Enrolling
Updated: 1/27/2009
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
Potential Modulatory Role of Osteoprotegerin in Bone Metabolism of Patients With 21-Hydroxylase Deficiency
Status: Enrolling
Updated:  6/1/2009
Mount Sinai School of Medicine
mi
from
New York, NY
Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
Potential Modulatory Role of Osteoprotegerin in Bone Metabolism of Patients With 21-Hydroxylase Deficiency
Status: Enrolling
Updated: 6/1/2009
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Status: Enrolling
Updated:  6/5/2009
Yale University School of Medicine
mi
from
New Haven, CT
Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Status: Enrolling
Updated: 6/5/2009
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Varying Characteristics of Atherogenesis and Cardiopulmonary Bypass Inflammatory Response
Phenotypic Variation in Atherogenesis and the Inflammatory Response to Cardiopulmonary Bypass
Status: Enrolling
Updated:  7/10/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Varying Characteristics of Atherogenesis and Cardiopulmonary Bypass Inflammatory Response
Phenotypic Variation in Atherogenesis and the Inflammatory Response to Cardiopulmonary Bypass
Status: Enrolling
Updated: 7/10/2009
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
Computerized PAINRelieveIt for Adult Sickle Cell Disease
Status: Enrolling
Updated:  7/24/2009
University of Illinois at Chicago Sickle Cell Center and Medical Center
mi
from
Chicago, IL
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
Computerized PAINRelieveIt for Adult Sickle Cell Disease
Status: Enrolling
Updated: 7/24/2009
University of Illinois at Chicago Sickle Cell Center and Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
Randomized Trial Comparing Early Versus Late Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates.
Status: Enrolling
Updated:  8/5/2009
University of Mississippi Medical Center
mi
from
Jackson, MS
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
Randomized Trial Comparing Early Versus Late Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates.
Status: Enrolling
Updated: 8/5/2009
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
Randomized Trial Comparing Early Versus Late Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates.
Status: Enrolling
Updated:  8/5/2009
Wake Forest University Baptist Medical Center
mi
from
Winston Salem, NC
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
Randomized Trial Comparing Early Versus Late Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates.
Status: Enrolling
Updated: 8/5/2009
Wake Forest University Baptist Medical Center
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
Randomized Trial Comparing Early Versus Late Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates.
Status: Enrolling
Updated:  8/5/2009
Ohio State University Medical Center
mi
from
Columbus, OH
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
Randomized Trial Comparing Early Versus Late Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates.
Status: Enrolling
Updated: 8/5/2009
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
Comparison of a Novel Silver-Coated Catheter Access Device and a Standard Catheter Access Device: A Dual Center Cross-Over Study
Status: Enrolling
Updated:  8/25/2009
Emory University Hospital Midtown
mi
from
Atlanta, GA
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
Comparison of a Novel Silver-Coated Catheter Access Device and a Standard Catheter Access Device: A Dual Center Cross-Over Study
Status: Enrolling
Updated: 8/25/2009
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
Comparison of a Novel Silver-Coated Catheter Access Device and a Standard Catheter Access Device: A Dual Center Cross-Over Study
Status: Enrolling
Updated:  8/25/2009
Emory University Hospital
mi
from
Atlanta, GA
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
Comparison of a Novel Silver-Coated Catheter Access Device and a Standard Catheter Access Device: A Dual Center Cross-Over Study
Status: Enrolling
Updated: 8/25/2009
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
St Francis Hospital
mi
from
Indianapolis, IN
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
St Francis Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
Kansas City Cancer Centers - BMT
mi
from
Kansas City, MO
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
Kansas City Cancer Centers - BMT
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
The Cancer Center at Hackensack University
mi
from
Hackensack, NJ
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
The Cancer Center at Hackensack University
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
Mt Sinai Hospital
mi
from
New York, NY
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
Mt Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
University of Rochester
mi
from
Rochester, NY
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
New York Medical College
mi
from
Valhalla, NY
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
M.D. Anderson Cancer Center
mi
from
Houston, TX
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  9/3/2009
Medical College of Wisconsin, FEC
mi
from
Milwaukee, WI
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 9/3/2009
Medical College of Wisconsin, FEC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six
Status: Enrolling
Updated:  9/9/2009
Yale Dermatology Associates
mi
from
New Haven, CT
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six
Status: Enrolling
Updated: 9/9/2009
Yale Dermatology Associates
mi
from
New Haven, CT
Click here to add this to my saved trials
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated:  9/21/2009
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated: 9/21/2009
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated:  9/21/2009
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated: 9/21/2009
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots
The Effect of a Levonorgestrel-releasing Intrauterine Device Versus a Copper Containing Intrauterine Device on Coagulation Parameters
Status: Enrolling
Updated:  1/15/2010
University of Vermont
mi
from
Burlington, VT
The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots
The Effect of a Levonorgestrel-releasing Intrauterine Device Versus a Copper Containing Intrauterine Device on Coagulation Parameters
Status: Enrolling
Updated: 1/15/2010
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure
Status: Enrolling
Updated:  6/15/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure
Status: Enrolling
Updated: 6/15/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Status: Enrolling
Updated:  7/2/2010
University of Chicago
mi
from
Chicago, IL
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Status: Enrolling
Updated: 7/2/2010
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis in ABO-compatible and Incompatible Healthy Term Newborn Infants.
Status: Enrolling
Updated:  8/4/2010
Crouse Hospital
mi
from
Syracuse, NY
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis in ABO-compatible and Incompatible Healthy Term Newborn Infants.
Status: Enrolling
Updated: 8/4/2010
Crouse Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis in ABO-compatible and Incompatible Healthy Term Newborn Infants.
Status: Enrolling
Updated:  8/4/2010
SUNY Upstate Medical University
mi
from
Syracuse, NY
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis in ABO-compatible and Incompatible Healthy Term Newborn Infants.
Status: Enrolling
Updated: 8/4/2010
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
Status: Enrolling
Updated:  8/9/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
Status: Enrolling
Updated: 8/9/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Phase II Study Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  8/11/2010
West Virginia University Hospitals Mary Babb Randolph Cancer Center
mi
from
Morgantown, WV
Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Phase II Study Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 8/11/2010
West Virginia University Hospitals Mary Babb Randolph Cancer Center
mi
from
Morgantown, WV
Click here to add this to my saved trials
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Extracorporeal Photopheresis for Steroid-refractory Acute GVHD in Children and Young Adults: a Safety and Feasibility Study.
Status: Enrolling
Updated:  10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Extracorporeal Photopheresis for Steroid-refractory Acute GVHD in Children and Young Adults: a Safety and Feasibility Study.
Status: Enrolling
Updated: 10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
Status: Enrolling
Updated:  10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
Status: Enrolling
Updated: 10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated:  10/22/2010
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated: 10/22/2010
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated:  10/22/2010
St. Christopher's Hospital for Children, Drexel University
mi
from
Philadelphia, PA
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated: 10/22/2010
St. Christopher's Hospital for Children, Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus
Phase II Study of the IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus in Patients With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  11/3/2010
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus
Phase II Study of the IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus in Patients With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 11/3/2010
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
An Iron Balance Study Comparing Deferasirox, Deferoxamine and the Combination of Both Drugs
Status: Enrolling
Updated:  11/4/2010
Weill Cornell Medical Center
mi
from
New York, NY
Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
An Iron Balance Study Comparing Deferasirox, Deferoxamine and the Combination of Both Drugs
Status: Enrolling
Updated: 11/4/2010
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia (BPD).
Status: Enrolling
Updated:  11/9/2010
UT-Houston Pediatric Surgery & Memorial Hermann Children's Hospital
mi
from
Houston, TX
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia (BPD).
Status: Enrolling
Updated: 11/9/2010
UT-Houston Pediatric Surgery & Memorial Hermann Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Status: Enrolling
Updated:  11/17/2010
New York Presbyterian Hospital
mi
from
White Plains, NY
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Status: Enrolling
Updated: 11/17/2010
New York Presbyterian Hospital
mi
from
White Plains, NY
Click here to add this to my saved trials
Study in Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adult Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  11/17/2010
Stanford University Cancer Institute
mi
from
Stanford, CA
Study in Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adult Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 11/17/2010
Stanford University Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Study in Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adult Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated:  11/17/2010
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Study in Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adult Patients With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Status: Enrolling
Updated: 11/17/2010
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques
The Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Artery Plaques in Patients With Moderate Coronary Artery Disease
Status: Enrolling
Updated:  12/6/2010
Emory University Hospital
mi
from
Atlanta, GA
Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques
The Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Artery Plaques in Patients With Moderate Coronary Artery Disease
Status: Enrolling
Updated: 12/6/2010
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials